Some companies are only looking to make the semaglutide peptide, which is the active ingredient, but more established players are planning to manufacture as well as market the drug. Among the companies planning to tap into the Indian market next year is Lupin, a well-known Indian generic-drug maker
Mounjaro drug interactions Mounjaro, a novel drug, has the potential to interact with various other medications, including insulin secretagogues, oral medications, and hormonal contraceptives
Dramatically lower prices
Tremfya (guselkumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $3.67 billion Why it sold so well: J&Js IL-23 inhibitor Tremfya experienced significant sales growth last year with $3.67 billion in total sales, an increase of 16.6% from 2023
Patients who continue high-calorie, carbohydrate-rich diets or remain sedentary may experience suboptimal results despite taking the medication correctly
High Energy Density : Packs a lot of power into a small space